Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:50:24.334Z.
Calculation as of: 2026-10-06T18:50:24.334Z.
Quote observation: 2026-10-06T18:49:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 473da95602fdb42a5f780e5c02853506da999e38a33e04168dea7648cb5c925f
EARNINGS YIELD
N/A
Market Cap
$63.47M
Earnings Yield
N/A
TTM Avg
2.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$62.50M
Earnings Yield
N/A
TTM Avg
34.60%
3Y Avg
34.60%
5Y Avg
34.60%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $63.58M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.47M | N/A | 2.54% | 2.54% | 2.54% |
| RenovoRx, Inc. (RNXT)vs › | $63.07M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.19M | N/A | 7.80% | 4.49% | 5.28% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.53M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.50M | N/A | 34.60% | 34.60% | 34.60% |
| Fractyl Health, Inc. (GUTS)vs › | $61.87M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.55M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.88M | N/A | 114.91% | 114.91% | 114.91% |
| iBio, Inc. (IBIO)vs › | $66.28M | N/A | 1.65% | 1.65% | 1.65% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
